
Advisory Board Strategy & Execution Framework
Design, recruit, and execute compliant strategic advisory boards for pharma commercial initiatives
What You Can Do
You can design advisory board strategies aligned to commercial milestones, recruit balanced advisor panels with clear role definitions, plan compliant meetings with structured facilitation protocols, and synthesize clinical insights into actionable regulatory and commercial strategy. This skill ensures every board engagement generates defensible clinical data while maintaining FDASIA transparency compliance, conflict-of-interest documentation, and audit trails.
Features
Define advisor roles, selection criteria, and balanced representation (geography, specialty, practice type) to build high-performing panels
Structure agendas, pre-reads, and discussion guides to extract clinical insights while maintaining compliance and engagement
Track advisor compensation, disclosures, conflicts of interest, and generate audit-ready records for regulatory inspection
Capture, organize, and translate advisor feedback into validated clinical narratives and competitive intelligence
Assess whether board is delivering insights aligned to original commercial and clinical objectives
Verify FDASIA transparency rules, anti-corruption compliance, and disclosure requirements before execution
Bridge clinical board insights to go-to-market positioning, key opinion leader engagement, and sales messaging
Map advisor recruitment cycles, meeting cadence, and refresh strategies to align with product development and market milestones
Example Output
Example 1: Advisory Board Design Brief
- Objective: Validate clinical narrative for new indication
- Advisor Profiles: 5 endocrinologists (3 academic, 2 community practice); 2 patient advocates; 1 payer representative
- Meeting Cadence: Quarterly for 18 months
- Compliance Requirements: FDASIA disclosure, honorarium documentation ($3,500/session), conflict-of-interest forms
- Key Discussion Topics: Real-world efficacy barriers, patient access challenges, reimbursement gaps
Example 2: Meeting Facilitation Guide
- Pre-read: Clinical efficacy data vs. competitor positioning
- Facilitation questions to surface: (1) treatment gaps in current practice, (2) barriers to adoption, (3) patient journey friction
- Insight capture: Thematic coding of responses, minority perspectives flagged, consensus areas identified
- Compliance documentation: Attendance log, advisor disclosures, intellectual property ownership (company-owned insights)
Example 3: Compliance Audit Trail
- Advisor roster with conflict-of-interest declarations and FDASIA transparency reporting
- Meeting agendas, attendee lists, and recorded discussion topics
- Compensation log with invoice/payment proof
- Synthesis document linking advisor input to commercial strategy decisions
What's Included
- SKILL.md instruction file with advisory board lifecycle framework:
- Advisor Recruitment Template: selection criteria, conflict-of-interest intake form, role definition matrix
- Meeting Facilitation Playbook: agenda templates, pre-read examples, discussion guides, real-time note-taking framework
- Compliance Checklist: FDASIA transparency checklist, conflict-of-interest documentation, regulatory filing requirements
- Insight Synthesis Worksheet: thematic coding template, competitive intelligence capture, strategic translation worksheet
- Board Performance Scorecard: metrics for assessing advisor panel effectiveness and alignment to commercial objectives
Who It's For
- Medical Affairs Managers — designing and executing advisory board strategies aligned to commercial milestones
- Regulatory Affairs Specialists — ensuring FDASIA compliance and transparency documentation across board activities
- Clinical Research Managers — recruiting advisors and synthesizing clinical insights for drug development decisions
- Commercial Strategy Teams — translating advisory board feedback into sales positioning and market access strategy
- Thought Leader Engagement Managers — maintaining long-term advisor relationships while managing compliance risk
Best For
- Designing new advisory boards for product launches or indication expansions
- Planning individual advisory board meetings with structured discussion guides
- Recruiting balanced advisor panels with conflict-of-interest screening
- Documenting compliance audit trails for regulatory inspection
- Synthesizing multi-advisor feedback into defensible clinical narratives
- Translating board insights into competitive intelligence and go-to-market strategy







